Sanofi-Aventis abruptly ended their relationship with Genta and yanked the submitted NDA off the table before it was ever ruled on by the FDA. This relationship was solely for the development of Genasense. They threw over 1 billion dollars down the drain to get out of the relationship with Genta when they pulled the NDA out of the FDA's hands and ended the partnership.
I can promise you, it's a fact that Sanofi-Aventis is not interested one IOTA in working with Genta to develop the same exact drug and drug application that they turned their back and walked out the door on, losing over 1 billion dollars.
Do some research on the partnership and how it ended.
News 
Market Data 
Discover 
